Kyoto, Japan

Hajime Fujmura

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajime Fujmura. Retrieved from https://idiyas.com/inventor/hajime-fujmura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hajime Fujmura: Innovator in Pharmaceutical Composition

Introduction

Hajime Fujmura is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic and anti-inflammatory compositions. His work has the potential to impact the medical community positively.

Latest Patents

Hajime Fujmura holds a patent for a pharmaceutical composition containing a 1,3,5-substituted biuret compound. This composition is designed to serve as an analgesic, anti-inflammatory, or anti-pyretic agent. The formula includes various substituents that enhance its effectiveness, making it a valuable addition to pharmaceutical formulations. He has 1 patent to his name.

Career Highlights

Fujmura is associated with Taiho Pharmaceutical Company Limited, where he has been instrumental in advancing research and development in pharmaceutical sciences. His innovative approach has led to the creation of new therapeutic options for patients.

Collaborations

Throughout his career, Hajime Fujmura has collaborated with esteemed colleagues such as Yasuzo Hiramatsu and Takahiro Yabuuchi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hajime Fujmura's contributions to pharmaceutical compositions highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…